Senators press Moderna CEO on COVID-19 vaccine price hike
Published
Before a Senate panel, Moderna’s CEO is defending a plan to more than quadruple the company’s COVID-19 vaccine price.
Full ArticlePublished
Before a Senate panel, Moderna’s CEO is defending a plan to more than quadruple the company’s COVID-19 vaccine price.
Full ArticleModerna Inc (NASDAQ: MRNA) has been in focus recently after revealing plans of raising price of its COVID shot by a staggering..
ViewThe head of Moderna is defending his company's decision to raise the price of its COVID-19 vaccine fivefold, despite receiving..